Skip to main content
Capricor Therapeutics, Inc. (CAPR)
NASDAQ: CAPR · Real-Time Price · USD
29.79
+1.89 (6.77%)
Mar 9, 2026, 3:07 PM EDT - Market open

Capricor Therapeutics Revenue

Capricor Therapeutics had revenue of $11.13M in the twelve months ending September 30, 2025, down -52.08% year-over-year. In the year 2024, Capricor Therapeutics had annual revenue of $22.27M, down -11.55%.

Revenue (ttm)
$11.13M
Revenue Growth
-52.08%
P/S Ratio
129.64
Revenue / Employee
$69,566
Employees
160
Market Cap
1.54B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202422.27M-2.91M-11.55%
Dec 31, 202325.18M22.63M886.81%
Dec 31, 20222.55M2.31M941.85%
Dec 31, 2021244.90K-65.35K-21.06%
Dec 31, 2020310.25K-694.78K-69.13%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Ardelyx 407.32M
Monte Rosa Therapeutics 181.54M
Nurix Therapeutics 83.98M
Vir Biotechnology 68.56M
Generate Biomedicines 31.89M
Zenas BioPharma 15.00M
Revenue Rankings

CAPR News

More News